Defibrion is listed on the portfolio pages of Holland Capital (portfolio page) and IK Partners (portfolio page). IK Partners lists it as current; Holland Capital lists it as exited. IK Partners has owned Defibrion since 2024, per IK Partners' portfolio page.
Defibrion is a Healthcare. company. Its owner on record, Holland Capital, is a venture firm. Holland Capital lists at least 75 companies in the index, 30 of them in Healthcare.. Also backed by IK Partners.
The firm provides growth and buy-out financing to technology and healthcare companies in the Benelux and Germany.
Read the Holland Capital profileIK Partners is a European private equity firm that invests in small- and mid-cap companies across Northern and Western Europe.
Read the IK Partners profileDefibrion is listed on the portfolio pages of Holland Capital (portfolio page) and IK Partners (portfolio page). IK Partners lists it as current; Holland Capital lists it as exited. IK Partners has owned Defibrion since 2024, per IK Partners' portfolio page.
Defibrion is in Healthcare.. Classified from the owner's portfolio label.
Holland Capital lists 29 other Healthcare. companies in the index, including Attenza, Blyott, Curess, Cytosmart and HealthConnected.
6 of 74 shown
See the full Holland Capital portfolio.
6 of 73 shown
See the full IK Partners portfolio.
Browse PE-backed companies.
